The Trump administration has proposed terminating a $56 million annual grant program that distributes naloxone, also known by ...

The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...

Previously called STS101, the company said Wednesday that the drug’s brand name is Atzumi and is indicated for acute migraine ...

A Utah manufacturer says the truth prevailed. But a former federal regulator believes the dismissal of the case against Xlear ...

Hello, mermaid hair! A few spritzes, a scrunch or twist of the fingers, and you’ll master the art of beach waves—shop options ...